Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Y Chang

Showing results (41-50 of 312) with videos related to

Pageof 32
Sort By:
JAMA Oncology|January 6, 2022
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget RadiotherapyJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Thoracic Surgery Clinics|August 13, 2013
Can stereotactic ablative radiotherapy in early stage lung cancers produce comparable success as surgery?Shervin M Shirvani, Joe Y Chang, Jack A Roth
Molecular Cancer|February 9, 2019
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issuesHongqing Zhuang, Siyu Shi, Zhiyong Yuan, et al.
Cancers|May 24, 2011
Cancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancersGiang Huong Nguyen, Mandi M Murph, Joe Y Chang
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2012
Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancerXiaochun Zhang, Bingliang Fang, Radhe Mohan, et al.
The Lancet. Oncology|December 2, 2021
SABR for operable stage I non-small-cell lung cancer: comparison to surgery - Authors' replyJoe Y Chang, Vivek Verma, Lei Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancerSteven P Register, Xiaodong Zhang, Radhe Mohan, et al.
The Lancet. Oncology|August 8, 2015
Surgery versus SABR for resectable non-small-cell lung cancer - Authors' replyJoe Y Chang, Suresh Senan, Egbert F Smit, et al.
Journal of Radiotherapy in Practice|April 11, 2022
Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beamsOleg N Vassiliev, Christine B Peterson, Joe Y Chang, et al.
Oncotarget|October 8, 2016
MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinomaHongqing Zhuang, Jing Bai, Joe Y Chang, et al.
Pageof 32

Showing results (41-50 of 312) with videos related to

Sort By:
Pageof 32
JAMA Oncology|January 6, 2022
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget RadiotherapyJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Thoracic Surgery Clinics|August 13, 2013
Can stereotactic ablative radiotherapy in early stage lung cancers produce comparable success as surgery?Shervin M Shirvani, Joe Y Chang, Jack A Roth
Molecular Cancer|February 9, 2019
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issuesHongqing Zhuang, Siyu Shi, Zhiyong Yuan, et al.
Cancers|May 24, 2011
Cancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancersGiang Huong Nguyen, Mandi M Murph, Joe Y Chang
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2012
Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancerXiaochun Zhang, Bingliang Fang, Radhe Mohan, et al.
The Lancet. Oncology|December 2, 2021
SABR for operable stage I non-small-cell lung cancer: comparison to surgery - Authors' replyJoe Y Chang, Vivek Verma, Lei Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancerSteven P Register, Xiaodong Zhang, Radhe Mohan, et al.
The Lancet. Oncology|August 8, 2015
Surgery versus SABR for resectable non-small-cell lung cancer - Authors' replyJoe Y Chang, Suresh Senan, Egbert F Smit, et al.
Journal of Radiotherapy in Practice|April 11, 2022
Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beamsOleg N Vassiliev, Christine B Peterson, Joe Y Chang, et al.
Oncotarget|October 8, 2016
MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinomaHongqing Zhuang, Jing Bai, Joe Y Chang, et al.
Pageof 32